Moderna, Inc. — Director's Dealing 2020

May 19, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2020-05-15

Reporting Person: Kim Lorence H. (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-15	Common Stock	S	2600	$63.80	Disposed	1219910	Direct
2020-05-15	Common Stock	S	5442	$64.96	Disposed	1214468	Direct
2020-05-15	Common Stock	S	9715	$66.05	Disposed	1204753	Direct
2020-05-15	Common Stock	S	2243	$66.68	Disposed	1202510	Direct
2020-05-18	Common Stock	M	29022	$14.22	Acquired	1231532	Direct
2020-05-18	Common Stock	M	211978	$12.21	Acquired	1443510	Direct
2020-05-18	Common Stock	S	3768	$76.45	Disposed	1439742	Direct
2020-05-18	Common Stock	S	7640	$77.48	Disposed	1432102	Direct
2020-05-18	Common Stock	S	18675	$79.40	Disposed	1413427	Direct
2020-05-18	Common Stock	S	35569	$80.24	Disposed	1377858	Direct
2020-05-18	Common Stock	S	16736	$81.43	Disposed	1361122	Direct
2020-05-18	Common Stock	S	56379	$82.28	Disposed	1304743	Direct
2020-05-18	Common Stock	S	59175	$83.33	Disposed	1245568	Direct
2020-05-18	Common Stock	S	33792	$84.27	Disposed	1211776	Direct
2020-05-18	Common Stock	S	5868	$85.16	Disposed	1205908	Direct
2020-05-18	Common Stock	S	2600	$86.54	Disposed	1203308	Direct
2020-05-18	Common Stock	S	798	$86.96	Disposed	1202510	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-05-18	Stock Option (Right to Buy)	$14.22	M	29022	Disposed	2028-02-28	Common Stock (29022)	Direct
2020-05-18	Stock Option (Right to Buy)	$12.21	M	211978	Disposed	2027-02-23	Common Stock (211978)	Direct

Footnotes

F1: This sale was effected pursuant to a Rule 10b5-1 trading plan.

F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.27 to $64.22. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.35 to $65.34. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.39 to $66.38. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.42 to $67.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F6: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan.

F7: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $76.13 to $76.86. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F8: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $77.15 to $78.05. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F9: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $78.75 to $79.75. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F10: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $79.78 to $80.78. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F11: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $80.80 to $81.79 shares sold at each separate price can be furnished to the SEC staff upon request.

F12: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $81.82 to $82.82. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F13: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $82.83 to $83.83. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F14: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $83.84 to $84.80. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F15: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $84.85 to $85.85. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F16: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.86 to $86.81. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F17: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $86.90 to $87.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F18: 458,715 of the options will vest over 4 years (25% on February 27, 2019, then quarterly for the next 3 years), 229,358 of the options will vest over 5 years (25% on February 27, 2020, then quarterly for the next 3 years), 229,358 of the options will vest over 6 years (25% on February 27, 2021, then quarterly for the next 3 years).

F19: 25% of this option vested and became exercisable on February 22, 2018, with the remainder vesting in 12 equal quarterly installments thereafter.